MEGAN KESTER: Open Payments
NPI 1184209884 · KERRVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 67 payments from 13 companies in 2025. Trend: 2023 $1,539 · 2024 $1,338 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 28 | $357 |
| E.R. Squibb & Sons, L.L.C. | 15 | $258 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| Alnylam Pharmaceuticals Inc. | 4 | $69 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| PFIZER INC. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $24 |
Products named: LEQVIO, CAMZYOS, ELIQUIS, JARDIANCE, LifeVest, ONPATTRO, Kerendia, FARXIGA.
Industry payments across TX — which companies pay providers there.
